Can MSC Therapy Help Chronic Lung Inflammation and Scarring?
Key Takeaways Mesenchymal stem cell (MSC) therapy has been tested in small human trials for chronic lung inflammation, but none show it reverses lung scarring. A 2013 randomized trial of 62 people with chronic obstructive pulmonary disease (COPD) found no lung function gain from infused MSCs. A 2020 randomized trial
October 15, 2026
No Comments
